Atomistry » Bromine » PDB 4alv-4d46 » 4bae
Atomistry »
  Bromine »
    PDB 4alv-4d46 »
      4bae »

Bromine in PDB 4bae: Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis

Enzymatic activity of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis

All present enzymatic activity of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis:
5.99.1.3;

Protein crystallography data

The structure of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis, PDB code: 4bae was solved by J.A.Read, H.G.Gingell, P.Madhavapeddi, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 59.19 / 2.35
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 59.191, 78.249, 89.750, 90.00, 90.01, 90.00
R / Rfree (%) 19.42 / 23.72

Other elements in 4bae:

The structure of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis also contains other interesting chemical elements:

Chlorine (Cl) 4 atoms
Calcium (Ca) 4 atoms

Bromine Binding Sites:

The binding sites of Bromine atom in the Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis (pdb code 4bae). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total 4 binding sites of Bromine where determined in the Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis, PDB code: 4bae:
Jump to Bromine binding site number: 1; 2; 3; 4;

Bromine binding site 1 out of 4 in 4bae

Go back to Bromine Binding Sites List in 4bae
Bromine binding site 1 out of 4 in the Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br1256

b:71.0
occ:1.00
BR3 A:RWX1256 0.0 71.0 1.0
C4 A:RWX1256 1.9 59.3 1.0
C3 A:RWX1256 2.9 54.5 1.0
C5 A:RWX1256 3.0 54.0 1.0
N9 A:RWX1256 3.3 60.2 1.0
CL3 A:RWX1256 3.5 50.7 1.0
C7 A:RWX1256 3.6 57.0 1.0
CG2 A:VAL125 3.7 55.4 1.0
CD1 A:ILE84 3.7 68.8 1.0
CB A:ASN52 3.7 49.4 1.0
CG1 A:VAL123 3.8 69.7 1.0
CG A:ASN52 3.9 62.2 1.0
CG1 A:ILE84 4.0 66.8 1.0
N6 A:RWX1256 4.1 51.6 1.0
C17 A:RWX1256 4.1 69.3 1.0
C2 A:RWX1256 4.1 51.7 1.0
CG2 A:VAL123 4.1 72.7 1.0
OD1 A:ASN52 4.2 56.6 1.0
ND2 A:ASN52 4.3 51.4 1.0
CG1 A:VAL99 4.4 66.3 1.0
C10 A:RWX1256 4.5 64.7 1.0
O16 A:RWX1256 4.5 71.5 1.0
CB A:VAL123 4.6 71.9 1.0
C15 A:RWX1256 4.7 69.5 1.0
O8 A:RWX1256 4.8 59.4 1.0

Bromine binding site 2 out of 4 in 4bae

Go back to Bromine Binding Sites List in 4bae
Bromine binding site 2 out of 4 in the Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 2 of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Br1255

b:65.5
occ:1.00
BR3 B:RWX1255 0.0 65.5 1.0
C4 B:RWX1255 1.9 52.9 1.0
C3 B:RWX1255 2.9 47.6 1.0
C5 B:RWX1255 3.0 48.2 1.0
CL3 B:RWX1255 3.4 43.8 1.0
N9 B:RWX1255 3.4 53.3 1.0
CD1 B:ILE84 3.6 56.8 1.0
C7 B:RWX1255 3.7 48.6 1.0
CG1 B:VAL123 3.7 57.9 1.0
CB B:ASN52 3.8 44.5 1.0
CG1 B:ILE84 3.9 57.9 1.0
CG B:ASN52 4.0 64.5 1.0
N6 B:RWX1255 4.1 48.3 1.0
C2 B:RWX1255 4.1 46.7 1.0
CG1 B:VAL125 4.2 49.0 1.0
C17 B:RWX1255 4.3 67.3 1.0
ND2 B:ASN52 4.3 46.1 1.0
OD1 B:ASN52 4.4 59.2 1.0
CG1 B:VAL99 4.4 64.4 1.0
O16 B:RWX1255 4.4 67.8 1.0
C10 B:RWX1255 4.6 58.2 1.0
CG2 B:VAL123 4.8 61.8 1.0
C15 B:RWX1255 4.8 63.3 1.0
CB B:VAL125 4.9 48.0 1.0
O8 B:RWX1255 4.9 49.3 1.0
CB B:VAL123 4.9 60.0 1.0

Bromine binding site 3 out of 4 in 4bae

Go back to Bromine Binding Sites List in 4bae
Bromine binding site 3 out of 4 in the Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 3 of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis within 5.0Å range:
probe atom residue distance (Å) B Occ
C:Br1256

b:61.4
occ:1.00
BR3 C:RWX1256 0.0 61.4 1.0
C4 C:RWX1256 1.9 49.5 1.0
C3 C:RWX1256 2.9 44.7 1.0
C5 C:RWX1256 3.0 43.2 1.0
CL3 C:RWX1256 3.3 40.5 1.0
N9 C:RWX1256 3.4 53.4 1.0
CD1 C:ILE84 3.6 59.9 1.0
C7 C:RWX1256 3.7 48.0 1.0
C17 C:RWX1256 3.8 63.2 1.0
CB C:ASN52 3.8 40.9 1.0
CG1 C:ILE84 3.8 56.3 1.0
CG1 C:VAL123 4.0 66.3 1.0
CG C:ASN52 4.1 62.6 1.0
C2 C:RWX1256 4.1 39.2 1.0
N6 C:RWX1256 4.1 39.5 1.0
CG1 C:VAL125 4.3 48.4 1.0
O C:HOH2010 4.4 33.8 1.0
CG1 C:VAL99 4.4 65.5 1.0
CG2 C:VAL123 4.4 69.8 1.0
ND2 C:ASN52 4.4 53.4 1.0
OD1 C:ASN52 4.4 65.1 1.0
O16 C:RWX1256 4.5 63.5 1.0
C10 C:RWX1256 4.6 55.6 1.0
C15 C:RWX1256 4.7 59.6 1.0
CB C:VAL123 4.9 68.8 1.0
O8 C:RWX1256 4.9 48.9 1.0

Bromine binding site 4 out of 4 in 4bae

Go back to Bromine Binding Sites List in 4bae
Bromine binding site 4 out of 4 in the Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 4 of Optimisation of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis within 5.0Å range:
probe atom residue distance (Å) B Occ
D:Br1257

b:60.4
occ:1.00
BR3 D:RWX1257 0.0 60.4 1.0
C4 D:RWX1257 1.9 44.5 1.0
C3 D:RWX1257 2.9 39.5 1.0
C5 D:RWX1257 3.0 38.8 1.0
N9 D:RWX1257 3.4 45.5 1.0
CL3 D:RWX1257 3.4 33.8 1.0
CD1 D:ILE84 3.6 50.1 1.0
C7 D:RWX1257 3.7 42.5 1.0
C17 D:RWX1257 3.7 64.6 1.0
CB D:ASN52 3.8 34.9 1.0
CG1 D:ILE84 3.8 53.8 1.0
CG D:ASN52 4.0 58.0 1.0
CG1 D:VAL123 4.1 59.0 1.0
C2 D:RWX1257 4.1 36.4 1.0
N6 D:RWX1257 4.1 34.9 1.0
O16 D:RWX1257 4.3 63.2 1.0
CG1 D:VAL99 4.4 60.3 1.0
O D:HOH2003 4.4 46.7 1.0
CG1 D:VAL125 4.4 44.8 1.0
ND2 D:ASN52 4.4 48.4 1.0
OD1 D:ASN52 4.4 50.9 1.0
CG2 D:VAL123 4.4 61.9 1.0
C10 D:RWX1257 4.6 49.6 1.0
C15 D:RWX1257 4.7 56.0 1.0
O8 D:RWX1257 4.9 44.9 1.0
CB D:VAL125 4.9 44.1 1.0
CB D:VAL123 4.9 61.4 1.0

Reference:

S.P.Hameed, S.Solapure, K.Mukherjee, V.Nandi, D.Waterson, R.Shandil, M.Balganesh, V.K.Sambandamurthy, A.K.Raichurkar, A.Deshpande, A.Ghosh, D.Awasthy, G.Shanbhag, G.Sheikh, H.Mcmiken, J.Puttur, J.Reddy, J.Werngren, J.Read, M.Kumar, M.R, M.Chinnapattu, P.Madhavapeddi, P.Manjrekar, R.Basu, S.Gaonkar, S.Sharma, S.Hoffner, V.Humnabadkar, V.Subbulakshmi, V.Panduga. Optimization of Pyrrolamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship and in Vivo Efficacy in the Mouse Model of Tuberculosis. Antimicrob.Agents Chemother. V. 58 61 2014.
ISSN: ISSN 0066-4804
PubMed: 24126580
DOI: 10.1128/AAC.01751-13
Page generated: Wed Jul 10 20:52:05 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy